First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer's drugs

An estimated 6.2 million Americans ages 65 and older are living with Alzheimer's disease. The national Alzheimer's Association predicts that number to grow to 13.8 million by 2060, barring the development of medical breakthroughs that would prevent, slow or cure the debilitating disease.

Related Keywords

United States ,Americans ,Wenrui Hao ,Jeffrey Petrella ,Suzanne Lenhart ,Emily Henderson ,Alzheimer Association ,Lab Diagnostics Automation ,University Of Tennessee ,Alzheimer Imaging Research Laboratory ,National Science Foundation ,Lab Diagnostics Automation Industry ,Duke University ,Penn State ,Automation Industry Focus ,National Science ,Clinical Trial ,Drugs ,Lzheimer 39s Disease ,Efficacy ,Research ,